在药物流行病学研究中预先注册高质量的协议
Henrik Larsson1, Zhang Chang2, Kenneth K C Man3
1School of Medical Sciences Örebro University Örebro Sweden.
JCPP advances
|December 15, 2025
概括
预先注册的协议提高了药物流行病学研究的透明度和可重复性. 这种方法有助于解决诸如选择性报告等挑战,并补充传统的随机临床试验.
科学领域:
- 药理流行病学 药理流行病学
- 临床研究方法论 临床研究方法论
背景情况:
- 药物流行病学研究是随机临床试验 (RCT) 的重要补充.
- 这些研究面临重大挑战,包括混和选择性报告.
- 现有的解决混问题的方法已经很成熟,但透明度问题仍然存在.
研究的目的:
- 讨论预先注册的协议在药物流行病学中的价值.
- 要强调预先注册如何提高透明度和可重复性.
- 解决药物流行病学中选择性报告的问题.
主要方法:
- 这是一个编辑的观点讨论现有的文学和概念.
- 专注于预先注册的协议的概念框架.
- 检查研究设计和报告的含义.
主要成果:
- 预先注册的协议提供了一个有价值的策略来缓解选择性报告.
- 增加透明度和可重复性是预先注册的关键好处.
- 这种方法加强了药理流行病学发现的可靠性.
结论:
- 预先注册的协议对于提高药物流行病学研究的质量至关重要.
- 采用预先注册是朝着更可靠的真实世界证据迈出的关键一步.
- 这种方法提高了药物安全研究的科学严谨性和可信度.
相关概念视频
Study Designs in Epidemiology
848
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
848
Bioavailability Study Design: Healthy Subjects Versus Patients
133
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
133
Dosage Regimens: Partial Pharmacokinetic Parameters
133
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
133
Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
380
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
380
Analysis of Population Pharmacokinetic Data
653
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
653


